The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Mayer, Howard, Dr
    Physician Researcher born in August 1962
    Individual (1 offspring)
    Officer
    2024-05-02 ~ now
    OF - Director → CIF 0
  • 2
    Ollier, Michele
    Partner At Medicxi Ventures born in June 1958
    Individual (7 offsprings)
    Officer
    2016-07-12 ~ now
    OF - Director → CIF 0
  • 3
    De Rubertis, Francesco
    Investor born in January 1970
    Individual (19 offsprings)
    Officer
    2021-06-25 ~ now
    OF - Director → CIF 0
  • 4
    Sekhri, Paul
    Partner At Medicxi Ventures born in April 1958
    Individual (1 offspring)
    Officer
    2023-10-06 ~ now
    OF - Director → CIF 0
  • 5
    Ring, Robert
    Ceo born in December 1967
    Individual (1 offspring)
    Officer
    2019-03-12 ~ now
    OF - Director → CIF 0
Ceased 6
  • 1
    Zweifach, Sanford
    Company Director born in March 1956
    Individual
    Officer
    2021-02-09 ~ 2023-10-06
    OF - Director → CIF 0
  • 2
    Vagner, Alex
    Director born in March 1959
    Individual
    Officer
    2017-04-21 ~ 2021-07-19
    OF - Director → CIF 0
  • 3
    Luthringer, Remy Henri
    Ceo born in November 1960
    Individual
    Officer
    2019-05-22 ~ 2021-07-14
    OF - Director → CIF 0
  • 4
    Perche, Olivier
    Engineer born in November 1981
    Individual
    Officer
    2021-06-29 ~ 2023-04-26
    OF - Director → CIF 0
  • 5
    Finet, Marie Henriette
    Scientific Officer born in November 1964
    Individual
    Officer
    2022-08-17 ~ 2024-05-02
    OF - Director → CIF 0
  • 6
    TCPI ASSET 1 LIMITED - 2013-04-10
    25, Fiddle Bridge Lane, Hatfield, Hertfordshire, England
    Active Corporate (4 parents, 32 offsprings)
    Equity (Company account)
    805,306 GBP2018-04-30
    Officer
    2016-07-12 ~ 2017-12-03
    PE - Secretary → CIF 0
    Person with significant control
    2016-07-12 ~ 2016-10-14
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
    PE - Has significant influence or control → CIF 0
parent relation
Company in focus

KAERUS BIOSCIENCE LIMITED

Previous name
FRAXADEV LIMITED - 2016-11-23
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
02023-01-01 ~ 2023-12-31
02021-08-01 ~ 2022-12-31
Fixed Assets - Investments
2 GBP2023-12-31
39,555 GBP2022-12-31
Debtors
Current
190,818 GBP2023-12-31
37,168 GBP2022-12-31
Cash at bank and in hand
2,483,729 GBP2023-12-31
815,624 GBP2022-12-31
Current Assets
2,674,547 GBP2023-12-31
852,792 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-597,899 GBP2023-12-31
-774,047 GBP2022-12-31
Net Current Assets/Liabilities
2,076,648 GBP2023-12-31
78,745 GBP2022-12-31
Net Assets/Liabilities
2,076,650 GBP2023-12-31
118,300 GBP2022-12-31
Equity
Called up share capital
646,326 GBP2023-12-31
418,467 GBP2022-12-31
Share premium
15,205,714 GBP2023-12-31
9,964,827 GBP2022-12-31
Retained earnings (accumulated losses)
-13,775,390 GBP2023-12-31
-10,264,994 GBP2022-12-31
Equity
2,076,650 GBP2023-12-31
118,300 GBP2022-12-31
Other Debtors
Current
186,370 GBP2023-12-31
36,518 GBP2022-12-31
Prepayments/Accrued Income
Current
4,448 GBP2023-12-31
650 GBP2022-12-31
Trade Creditors/Trade Payables
Current
69,423 GBP2023-12-31
217,895 GBP2022-12-31
Amounts owed to group undertakings
Current
355,548 GBP2022-12-31
Accrued Liabilities/Deferred Income
Current
528,476 GBP2023-12-31
200,604 GBP2022-12-31
Creditors
Current
597,899 GBP2023-12-31
774,047 GBP2022-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
890,750 shares2023-12-31
890,750 shares2022-12-31
Par Value of Share
Class 1 ordinary share
0.012023-01-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
22,050,000 shares2023-12-31
22,050,000 shares2022-12-31
Par Value of Share
Class 2 ordinary share
0.012023-01-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
8,812,003 shares2023-12-31
8,812,003 shares2022-12-31
Par Value of Share
Class 3 ordinary share
0.012023-01-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
566,280 shares2023-12-31
Par Value of Share
Class 4 ordinary share
0.012023-01-01 ~ 2023-12-31
  • KAERUS BIOSCIENCE LIMITED
    Info
    FRAXADEV LIMITED - 2016-11-23
    Registered number 10274924
    2nd Floor 168 Shoreditch High Street, London E1 6RA
    Private Limited Company incorporated on 2016-07-12 (8 years 11 months). The company status is Active.
    The last date of confirmation statement was made at 2024-07-11
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.